Business● Low3h ago · Nov 5, 2026, 8:19 AM
Aprea Therapeutics GAAP EPS of -$0.09 in-line
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Aprea Therapeutics reported GAAP EPS of -$0.09, which was in line with expectations. This is a routine financial announcement for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business26m agoDuke Energy beats top-line and bottom-line estimates; narrows FY26 outlookSeeking Alpha TechBusiness26m agoCelsius Non-GAAP EPS of $0.41 beats by $0.07, revenue of $847.2M beats by $46.54MSeeking Alpha TechBusiness27m agoDorian LPG Non-GAAP EPS of $3.46 beats by $0.62, revenue of $221.3M beats by $32.93MSeeking Alpha TechBusiness27m agoOscar Health GAAP EPS of $0.49 beats by $0.66, revenue of $5.14B beats by $420MSeeking Alpha Tech